Prosecution Insights
Last updated: November 11, 2026
Application No. 18/221,602

PRE-FILLED MULTI-FLUID MEDICAL DELIVERY ASSEMBLIES

Final Rejection §112
Filed
Jul 13, 2023
Priority
Feb 26, 2021 — provisional 63/154,280 +1 more
Examiner
FREDRICKSON, COURTNEY B
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Koska Family Limited
OA Round
2 (Final)
75%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
311 granted / 413 resolved
+5.3% vs TC avg
Strong +30% interview lift
Without
With
+29.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
44 currently pending
Career history
465
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
40.9%
+0.9% vs TC avg
§102
19.3%
-20.7% vs TC avg
§112
31.1%
-8.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 413 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment This office action is responsive to the amendment filed on April 15, 2026. As directed by the amendment: claims 1, 12, 19, and 21 have been amended, claim 18 has been cancelled, and claims 23-27 have been added. Thus, claims 1-17 and 19-27 are presently pending in this application. Response to Arguments Applicant’s arguments, filed April 15, 2026, with respect to the 103 rejection to claim 1 have been fully considered and are persuasive, specifically in regards to the prior art not teaching or disclosing the newly claimed limitations. The 103 rejection of claim 1 has been withdrawn. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 23-27 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claim 23, the claim recites “the outlet port” in the last line of the claim. It is unclear if this outlet port is in reference to the first or the second outlet port introduced earlier in the claim. Additionally, the limitation “the I/O port” lacks antecedent basis in the claim. For examination purposes, “the outlet port” is considered in reference to the first outlet port and “the I/O port” is considered in reference to the second outlet port. Claims 24-27 are also rejected by virtue of being dependent on claim 23. Allowable Subject Matter Claims 1-17 and 19-22 are allowed over the prior art of record. Claims 23-27 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. The following is an examiner’s statement of reasons for allowance: The claims in this application are allowed because the prior art of record fails to disclose either singly or in combination the claimed pre-filled medical delivery assembly. The closest prior art of record is Lev in view of Poynter. Regarding independent claim 1, modified Lev fails to teach among all the limitations or render obvious the at least one administration conduit being utilized to administer the combination of the first and second fluid agents when coupled to the second connector, in combination with the total structure and function as claimed. Instead, Lev teaches an administration assembly (syringe 10 in fig. 1) which is adapted to couple to the I/O port of the second connector when the first connector is released from the second connector (paragraph 9) and which comprises an administration conduit which can receive the claimed combination of fluid agents (paragraph 10). However, in order to administer the claimed combination of fluid agents, the second connector needs to be disconnected from the administration conduit so a needle can be attached to the syringe (paragraph 11). As such, the conduit is not utilized to administer the agents when coupled to the second connector, as required by the claim. Regarding independent claim 12, the claim is allowed for the same reasons provided in the Non-Final Rejection mailed on 1/15/2026. Regarding independent claim 23, modified Lev fails to teach among all the limitations or render obvious the first/second neck comprising one of a toroidal or donut-shaped protrusion on an outer surface thereof, in combination with the total structure and function as claimed. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to COURTNEY FREDRICKSON whose telephone number is (571)270-7481. The examiner can normally be reached Monday-Friday (9 AM - 5 PM EST). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, BHISMA MEHTA can be reached at 571-272-3383. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /COURTNEY FREDRICKSON/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Jul 13, 2023
Application Filed
Jan 15, 2026
Non-Final Rejection mailed — §112
Apr 15, 2026
Response Filed
Aug 26, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773545
NEEDLELESS CONNECTOR HAVING CHECK VALVE WITH ASYMMETRIC VALVE DESIGN AND PRIMARY SEAL SUPPORT
5y 5m to grant Granted Oct 27, 2026
Patent 12773483
BREAST PUMP
3y 6m to grant Granted Oct 27, 2026
Patent 12766289
DOUBLE-LUMEN CATHETER
4y 10m to grant Granted Oct 20, 2026
Patent 12766076
ENTERAL FEEDING PUMP DOCKING STATION HAVING INTEGRATED FLUSH MODULE
3y 4m to grant Granted Oct 20, 2026
Patent 12766035
Surgical System Priming With Pressure Calibration
2y 10m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
75%
Grant Probability
99%
With Interview (+29.7%)
3y 1m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 413 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month